VFA
IMGN

Virtus Fund Advisers’s Immunogen Inc IMGN Stock Holding History

Virtus Fund Advisers’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$346K Buy
+53,977
New +$333K ﹤0.01% 413
2014
Q3 		– Sell
-7,322
Closed -$87K – 2045
2014
Q2 		$87K Buy
+7,322
New +$91.9K ﹤0.01% 1499

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtus Fund Advisers's IMGN Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Immunogen Inc (IMGN) in Q4 2017: 53,977 shares worth $346K. The stake represents ﹤0.01% of the portfolio and ranks #413 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in IMGN as recently as Q2 2014.

Virtus Fund Advisers first reported a position in IMGN in Q2 2014 and has held it in 2 quarters since. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2017.

  • Virtus Fund Advisers held 53,977 shares of Immunogen Inc worth $346K as of Q4 2017.
  • Immunogen Inc was a new Virtus Fund Advisers position in Q4 2017.
  • Immunogen Inc made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #413 holding.
  • Virtus Fund Advisers first reported a position in Immunogen Inc in Q2 2014 and has held it in 2 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.